Annals of Hepatology: 2023, vol: , issue:
- 1)- Fernando M Paschoal-Jr, Ricardo C Nogueira, Karla de Almeida Lins Ronconi, Marcelo de Lima Oliveira, Kelson James Almeida, Ivana Schmidtbauer Rocha, Eric Homero Albuquerque Paschoal, Joelma Karin Sagica Fernandes Paschoal, Luiz Augusto Carneiro D'Albuquerque, Manoel Jacobsen Teixeira, Ronney B Panerai, Edson Bor-Seng-Shu. TCD assessment in fulminant hepatic failure: Improvements in cerebral autoregulation after liver transplantation. Annals of hepatology. 2023, 29 (2): 101167
Cited : 0Read More - 2)- Shahana Prakash, Tomohiro Tanaka. The landscape of inpatient admissions for alcoholic hepatitis in the era of early liver transplantation. Annals of hepatology. 2023, 29 (2): 101169Cited : 1Read More
- 3)- Inah Marie C Aquino, Devis Pascut. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care. Annals of hepatology. 2023, 29 (2): 101176Cited : 1Read More
- 4)- Hui Han, Qingtao Yu, Nina Qin, Bin Song, Yan Meng, Zuojing Feng, Zhaoping Li, Liyong Chen. Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality. Annals of hepatology. 2023, 29 (2): 101177Cited : 3Read More
- 5)- Siyu Fu, Dhamina Karim, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z Mattos, Marco Arrese, Enrique Carrera, Jeffrey Oliveira, Jose D Debes, Andre Boonstra. Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans. Annals of hepatology. 2023, 29 (2): 101181Cited : 4Read More
- 6)- Andrea Del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, Varenka J Barbero-Becerra. Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents. Annals of hepatology. 2023, 29 (2): 101182Cited : 3Read More
- 7)- Genglin Zhang, Sensen Wu, Guangtao Xia. MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis. Annals of hepatology. 2023, 29 (2): 101183Cited : 0Read More
- 8)- Alex Bofill, Andrés Cárdenas. A practical approach to the endoscopic management of biliary strictures after liver transplantation. Annals of hepatology. 2023, 29 (2): 101186Cited : 1Read More
- 9)- Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal, Fasiha Kanwal, Diana Romero, Manal F Abdelmalek, Quentin M Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher D Byrne, Graciela E Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna R Cryer, Kenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D Guy, Stephen A Harrison, Seung Up Kim, Bart G Koot. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals of hepatology. 2023, 29 (1): 101133Cited : 202Read More
- 10)- Yan Gu, Yao Zhang, Zhiyi Zhang, Jian Wang, Qing Zhang, Shaoqiu Zhang, Yilin Liu, Jiacheng Liu, Juan Xia, Xiaomin Yan, Jie Li, Xingxiang Liu, Rui Huang, Chao Wu. A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues. Annals of hepatology. 2023, 29 (1): 101151Cited : 1Read More
- 11)- Kurt Grüngreiff, Dirk Reinhold, Wolfgang Maret. Why a pinch of zinc in liver disease matters. Annals of hepatology. 2023, 29 (1): 101152Cited : 0Read More
- 12)- Caecilia Hc Sukowati, Korri El-Khobar, Chyntia Olivia Maurine Jasirwan, Juferdy Kurniawan, Rino Alvani Gani. Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? Annals of hepatology. 2023, 29 (1): 101153Cited : 0Read More
- 13)- Renling Yao, Sufang Lu, Ruifei Xue, Jian Wang, Yuanwang Qiu, Yuxin Chen, Jiacheng Liu, Li Zhu, Jie Zhan, Suling Jiang, Shengxia Yin, Xin Tong, Weimao Ding, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study. Annals of hepatology. 2023, 29 (1): 101155Cited : 0Read More
- 14)- Marina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia. Annals of hepatology. 2023, 29 (1): 101156Cited : 2Read More
- 15)- Natalia Salinas Parra, Michelle Schafer, Heather M Ross, John Bruckbauer, Brian Yan, Sarah L Chen, Adnan Khan, Danielle M Tholey, Dina Halegoua-DeMarzio. Prevalence of post-liver transplant complications and NASH-related cirrhosis in postmenopausal women. Annals of hepatology. 2023, 29 (1): 101157Cited : 0Read More
- 16)- Jiaying Wu, Jiayao He, Hongmei Xu. Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis. Annals of hepatology. 2023, 29 (1): 101158Cited : 4Read More
- 17)- Xingyuan Hao, Jinghua Li, Bin Liu, Wei Jing, Yonghua Guo, Fusheng Liu, Xiaomian Li, Xi Chen, Yufeng Yuan, Weijie Ma. Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma. Annals of hepatology. 2023, 29 (1): 101160Cited : 1Read More
- 18)- Helena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller. Alcohol-associated liver disease: Epidemiology and management. Annals of hepatology. 2023, 29 (1): 101162Cited : 11Read More
- 19)- Aimen Waqar Khan, Sarah Waqar Khan. Surgical resection versus transcatheter arterial chemoembolization for large hepatocellular carcinoma: a deeper insight. Annals of hepatology. 2023, 29 (1): 101163Cited : 0Read More
- 20)- Lauren Loeb, Jason Lewis, Zhongwei Peng, Michael G Heckman, Raouf Nakhleh, Andrew P Keaveny. A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomes. Annals of hepatology. 2023, 29 (1): 101164Cited : 0Read More
- 21)- Eric David Ornos, Janus P Ong. Balancing perspectives: Schistosomiasis in the liver disease landscape of the Philippines. Annals of hepatology. 2023, 29 (1): 101165Cited : 0Read More
- 22)- Alexander M Sy. Schistosomiasis: A neglected cause of liver disease in the Philippines. Annals of hepatology. 2023, 29 (1): 101166Cited : 0Read More
- 23)- Fakhar Ali Qazi Arisar, Rhea Varghese, Shiyi Chen, Wei Xu, Markus Selzner, Ian McGilvray, Blayne Sayed, Trevor Reichman, Chaya Shwaartz, Mark Cattral, Anand Ghanekar, Gonzalo Sapisochin, Elmar Jaeckel, Cynthia Tsien, Nazia Selzner, Leslie Lilly, Mamatha Bhat. Trajectories of patients relisted for liver transplantation. Annals of hepatology. 2023, 29 (1): 101168Cited : 0Read More
- 24)- Zhiyi Zhang, Jian Wang, Huali Wang, Yiguang Li, Li Zhu, Yun Chen, Jiacheng Liu, Yilin Liu, Yuxin Chen, Shengxia Yin, Xin Tong, Xiaomin Yan, Yongfeng Yang, Chuanwu Zhu, Jie Li, Yuanwang Qiu, Rui Huang, Chao Wu. Develop and validate a novel online AIHI-nomogram to predict severe liver inflammation in patients with autoimmune hepatitis. Annals of hepatology. 2023, 28 (6): 101134Cited : 1Read More
- 25)- Jing Yang, Suxin Li, Shengyan Liu, Yuehui Zhang, Dongqi Shen, Peiju Wang, Xiaowei Dang. Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1α signaling pathway. Annals of hepatology. 2023, 28 (6): 101135Cited : 2Read More
- 26)- Yuan Chang, Tianyu Guo, Bo Zhu, Yefu Liu. A novel nomogram for predicting microvascular invasion in hepatocellular carcinoma. Annals of hepatology. 2023, 28 (6): 101136Cited : 2Read More
- 27)- Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of hepatology. 2023, 28 (6): 101137Cited : 2Read More
- 28)- Mariana M Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez. Metabolic dysfunction: The silenced connection with fatty liver disease. Annals of hepatology. 2023, 28 (6): 101138Cited : 9Read More
- 29)- Aldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas, María Sarai González-Huezo, José Luís Pérez-Hernández, Osvely Méndez-Guerrero, Jesús Alejandro Ruiz-Manríquez, Rafael Trejo-Estrada, Norberto C Chavez-Tapia, Luis Carlos Solís-Gasca, Carlos Moctezuma-Velázquez, Jonathan Aguirre-Valádez, Judith Flores-Calderón, Fatima Higuera-de-la-Tijera, Ignacio García-Juárez, Nancy Allin Canedo-Castillo, René Malé-Velázquez, Iaarah Montalvo-Gordo. Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology. Annals of hepatology. 2023, 28 (6): 101140Cited : 1Read More
- 30)- Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, Valérie Vilgrain, Edouard Larrey, Chetana Lim, Olivier Scatton, Sanaa El Mouhadi, Violaine Ozenne, François Paye, Pierre Balladur, Anthony Dohan, Pierre-Philippe Massault, Stanislas Pol, Marco Dioguardi Burgio, Ailton Sepulveda, Francois Cauchy, Alain Luciani, Daniele Sommacale, Vincent Leroy, Julien Calderaro, Francoise Roudot-Thoraval, Jean-Charles Nault. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later? Annals of hepatology. 2023, 28 (6): 101141Cited : 0Read More
- 31)- Lucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M Irvine, Suzanne Williams, Gaurav Puri, Patricia C Valery, Kelly L Hayward, Elizabeth E Powell. Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of hepatology. 2023, 28 (6): 101142Cited : 4Read More
- 32)- Haotang Ren, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhongji Meng, Yanhang Gao, Zhiping Qian, Feng Liu, Xiaobo Lu, Jia Shang, Shaoyang Wang, Shan Yin, Wenting Tan, Yixin Hou, Shue Xiong, Liyuan Long, Beiling Li, Sen Luo, Weituo Zhang, Yu Shi. Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis. Annals of hepatology. 2023, 28 (6): 101147Cited : 1Read More
- 33)- Jinhuan Wang, Xinmin Jin. Analysis of the impact of fatty acid metabolism on immunotherapy for hepatocellular carcinoma. Annals of hepatology. 2023, 28 (6): 101148Cited : 1Read More
- 34)- Spencer Goble, Angelo Z Mattos, Manuel Mendizabal, Jose D Debes. Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention. Annals of hepatology. 2023, 28 (6): 101149Cited : 1Read More
- 35)- Roberta Gagliardi, Nicola Zeni, Salvatore Piano. Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives. Annals of hepatology. 2023, 28 (6): 101150Cited : 0Read More
- 36)- Yusuf Yilmaz. Brushing your teeth may be good for your liver: Linking oral health to non-alcoholic fatty liver disease. Annals of hepatology. 2023, 28 (6): 101159Cited : 1Read More
- 37)- Yalcin Golcuk, Burcu Kaymak Golcuk. Prognostic value of lactate/albumin ratio in patients with acute-on-chronic liver failure. Annals of hepatology. 2023, 28 (6): 101161Cited : 0Read More
- 38)- Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou. Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms. Annals of hepatology. 2023, 28 (5): 101121Cited : 3Read More
- 39)- Zhenfei Chi, Yun Teng, Yuting Liu, Lu Gao, Junhan Yang, Zhe Zhang. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007-2016. Annals of hepatology. 2023, 28 (5): 101125Cited : 6Read More
- 40)- Muhammad A Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N Merwat, Syed A Hussain, Michael Kueht, Aftab Karim, Muhammad W Khattak, Peggy J Rooney, Khurram Jamil. Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older. Annals of hepatology. 2023, 28 (5): 101126Cited : 1Read More
- 41)- Carlos Benítez, Jorge Arnold, Verónica Cambindo, Fernanda Schoenfeldt, Alejandra Cancino, Samuel Ibáñez, Catalina Grandy, Paola Hunfan, Jorge González, Catalina Guerra, Esteban Godoy, Verónica Araneda, Constanza Mollo, Jaime Poniachik, Alvaro Urzúa, Máximo Cattaneo, Juan Pablo Roblero, Ilan Oppenheimer, Vicente Pizarro. Effect of acute on chronic liver failure over post-transplant survival. Annals of hepatology. 2023, 28 (5): 101128Cited : 2Read More
- 42)- Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018. Annals of hepatology. 2023, : 101154Cited : 3Read More
- 43)- Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V Lazarus, Marco Arrese. The burden of liver disease in Latin America. Annals of hepatology. 2023, : 101175Cited : 2Read More
- 44)- Manuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos. Evolving portal hypertension through Baveno VII recommendations. Annals of hepatology. 2023, : 101180Cited : 3Read More
- 45)- Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Cláudio Augusto Marroni, Alfeu de Medeiros Fleck Junior, Matheus V Fernandes, Marcos Mucenic. Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study. Annals of hepatology. 2023, : 101184Cited : 0Read More
- 46)- Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner. From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Annals of hepatology. 2023, : 101185Cited : 2Read More
- 47)- Maria Jimenez-Ramos, Timothy J Kendall, Ignat Drozdov, Jonathan A Fallowfield. A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease. Annals of hepatology. 2023, : 101278Cited : 1Read More
- 48)- Shuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, Mo Chen, Junping Wang, Yu He. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells. Annals of hepatology. 2023, : 101279Cited : 2Read More
- 49)- Shan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei. From NAFLD to MASLD: When metabolic comorbidity matters. Annals of hepatology. 2023, : 101281Cited : 4Read More
- 50)- Leandro Sierra, Ana Marenco-Flores, Romelia Barba, Daniela Goyes, Bryan Ferrigno, Wilfor Diaz, Esli Medina-Morales, Behnam Saberi, Vilas R Patwardhan, Alan Bonder. Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. Annals of hepatology. 2023, : 101283Cited : 4Read More
